Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotypic vs Susceptibility Guided Therapy for H. Pylori
NCT03556254Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Mar 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clarithromycin, levofloxacin in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
clarithromycinlevofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03556254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03556254.